Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Novartis' OAV101 IT gene therapy showed positive results in Phase 3 trials for SMA, with data supporting its potential as a ...

HealthEquity reported 19% revenue growth but missed Q4 EPS estimates. Analysts see earnings improving as cybersecurity costs ...

Visionary Holdings's GV short percent of float has risen 43.77% since its last report. The company recently reported that it ...

Intel shares are trading lower on Wednesday, pulling back after recent gains driven by the announcement of its next CEO.

Nike reports third-quarter financial results Thursday. Analysts expect declines in revenue and earnings per share. A look at ...

Anheuser-Busch InBev's BUD short percent of float has risen 7.55% since its last report. The company recently reported that ...

Immunovant's batoclimab showed positive Phase 3 results in MG but won't be pursued for approval as the company shifts focus ...

Compared to its industry, the company has higher Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of ...

In Italy, labor rights are deeply entrenched, with strong unions and strict protections against arbitrary job cuts. Roberto ...

Pepe, Fartcoin, and Bonk post double-digit gains over the past seven days, outperforming meme coin giants DOGE, SHIB. Traders ...

Servier announces a strategic worldwide licensing agreement for Black Diamond Therapeutics' BDTX-4933 for solid tumors for an ...